Genomics Market Size, Share, Trends, Growth Outlook

Genomics Market is estimated to increase at a Compounded Annual Growth Rate of 18.3% CAGR over the forecast period from 2024 to 2030

The Genomics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal research, Others), By Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), By End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical & Biotechnology companies, Others).

An Introduction to Genomics Market in 2024

Genomics is a field of molecular biology that focuses on the study of an organism's entire genome, including its structure, function, evolution, and interactions with the environment. In 2024, genomics continues to drive groundbreaking discoveries and innovations in biomedical research, personalized medicine, and agriculture, offering insights into the genetic basis of health, disease, and biological diversity. Advances in next-generation sequencing (NGS) technologies, bioinformatics, and data analysis have revolutionized genomics research, enabling rapid and cost-effective sequencing of entire genomes, transcriptomes, and epigenomes across diverse species and populations. By deciphering the genetic code and identifying variations such as single nucleotide polymorphisms (SNPs), copy number variations (CNVs), and structural rearrangements, genomics provides valuable information about disease susceptibility, drug response, and gene function, facilitating the development of precision therapies and targeted interventions tailored to individual patients' genetic profiles. Moreover, with the integration of multi-omics approaches, systems biology, and artificial intelligence (AI), genomics offers a comprehensive understanding of complex biological systems and disease pathways, driving translational research and the development of novel diagnostic tools and therapeutic strategies. By unlocking the secrets of the genome and harnessing its potential to improve human health, genomics holds promise for revolutionizing healthcare delivery, disease prevention, and personalized medicine in the 21st century.

Market Trend: Rapid Advancements in Next-Generation Sequencing (NGS) Technologies

A significant trend in the genomics market is the rapid advancements in next-generation sequencing (NGS) technologies. As NGS platforms continue to evolve, there is a growing ability to generate vast amounts of genomic data quickly and cost-effectively. This trend is driven by innovations in sequencing chemistry, bioinformatics, and automation, enabling researchers and clinicians to explore the complexities of the genome with unprecedented resolution and accuracy. The increasing accessibility of NGS technologies has democratized genomic research and clinical applications, leading to widespread adoption across various fields, including precision medicine, agricultural genomics, and microbiology. As NGS becomes more integrated into research and clinical workflows, the demand for genomic solutions and services is expected to grow, driving market expansion and driving further innovation in genomic technologies.

Market Driver: Rising Demand for Personalized Medicine and Precision Health

A key driver fueling the genomics market is the rising demand for personalized medicine and precision health solutions. Genomic information plays a critical role in guiding clinical decision-making, disease risk assessment, and therapeutic interventions tailored to individual patients' genetic profiles. With advancements in genomic technologies and bioinformatics, healthcare providers can identify genetic variants associated with disease susceptibility, drug response, and treatment outcomes, enabling more precise and personalized patient care. Additionally, the growing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and genetic disorders, underscores the importance of genomics in early detection, prevention, and management. As the healthcare industry shifts towards value-based care models and patient-centric approaches, the demand for genomic testing and interpretation services is expected to increase, driving market growth and driving further investment in genomic research and innovation.

Market Opportunity: Integration of Genomics with Artificial Intelligence (AI) and Machine Learning (ML)

A potential opportunity in the genomics market lies in the integration of genomics with artificial intelligence (AI) and machine learning (ML) algorithms. AI and ML technologies have the potential to revolutionize genomic analysis by automating data interpretation, identifying disease-associated patterns, and predicting treatment responses based on genomic data. By leveraging AI-driven algorithms, researchers and clinicians can accelerate genomic discoveries, uncover novel genetic associations, and develop more effective diagnostic and therapeutic strategies. Additionally, AI-powered genomic tools can enhance data mining, data visualization, and knowledge discovery from large-scale genomic datasets, enabling more comprehensive understanding of complex genetic traits and disease mechanisms. By integrating genomics with AI and ML, companies can offer innovative solutions that improve genomic analysis workflows, enhance clinical decision support, and advance precision medicine initiatives. Expanding into AI-driven genomics presents a strategic opportunity for companies to differentiate themselves in the market, drive innovation, and address unmet needs in genomic research and healthcare.

Genomics Market Share Analysis: Sequencing Technology is the fastest growing segment over the forecast period to 2030

Among the various segments in the genomics market, sequencing technology stands out as the fastest-growing segment, and several factors contribute to this trend. First and foremost, the advent of next-generation sequencing (NGS) technologies has revolutionized genomic research by enabling rapid, cost-effective, and high-throughput sequencing of nucleic acids. NGS platforms offer unparalleled insights into the structure, function, and variation of genomes, driving their widespread adoption across diverse applications such as drug discovery, diagnostics, agriculture, and biomarker discovery. Additionally, continuous advancements in sequencing technologies, including improvements in read lengths, accuracy, and throughput, enhance their utility in addressing complex biological questions and uncovering novel genetic insights. Furthermore, the declining cost of sequencing and the availability of user-friendly bioinformatics tools further fuel the adoption of sequencing technologies across various end-user segments, including academic and research institutes, pharmaceutical, and biotechnology companies. As a result, sequencing technology emerges as the primary driver of growth in the genomics market, poised to shape the future of genomic research and applications.

Genomics Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across10x Genomics Inc, 23andMe Inc, Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc, Creative Biogene, Danaher Corp, Eppendorf AG , Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Freenome Holdings Inc, Illumina Inc, Merck KGaA, New England Biolabs Inc, Novogene Co. Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Promega Corp, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc, Ultima Genomics Inc

Genomics Market Segmentation

By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Genomics Market Companies

10x Genomics Inc
23andMe Inc
Abbott Laboratories
Agilent Technologies Inc
Becton, Dickinson and Company
BGI Group
Bio-Rad Laboratories Inc
Creative Biogene
Danaher Corp
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Freenome Holdings Inc
Illumina Inc
Merck KGaA
New England Biolabs Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Ultima Genomics Inc

Reasons to Buy the Genomics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Genomics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Genomics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Genomics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Genomics Market Size Outlook, $ Million, 2021 to 2030
3.2 Genomics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Genomics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Genomics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Genomics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Genomics Industry
4.2 Key Market Trends in Genomics Industry
4.3 Potential Opportunities in Genomics Industry
4.4 Key Challenges in Genomics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Genomics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Genomics Market Outlook by Segments
7.1 Genomics Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others

8 North America Genomics Market Analysis and Outlook To 2030
8.1 Introduction to North America Genomics Markets in 2024
8.2 North America Genomics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Genomics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others

9 Europe Genomics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Genomics Markets in 2024
9.2 Europe Genomics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Genomics Market Size Outlook by Segments, 2021-2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others

10 Asia Pacific Genomics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Genomics Markets in 2024
10.2 Asia Pacific Genomics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Genomics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others

11 South America Genomics Market Analysis and Outlook To 2030
11.1 Introduction to South America Genomics Markets in 2024
11.2 South America Genomics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Genomics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others
12 Middle East and Africa Genomics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Genomics Markets in 2024
12.2 Middle East and Africa Genomics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Genomics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
10x Genomics Inc
23andMe Inc
Abbott Laboratories
Agilent Technologies Inc
Becton, Dickinson and Company
BGI Group
Bio-Rad Laboratories Inc
Creative Biogene
Danaher Corp
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Freenome Holdings Inc
Illumina Inc
Merck KGaA
New England Biolabs Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Ultima Genomics Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)